Anticoagulation during use of a left ventricular assist device

ASAIO Journal

Volumn 46, Issue 3, 2000, Pages 354-357

  Takahama, Tatsuhiko ^a,b   Kanai, Fukuei ^a   Onishi, Kiyoshi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; COAGULATION; DRUG PRODUCTS; LIVING SYSTEMS STUDIES;

ANTICOAGULATION; LEFT VENTRICULAR ASSIST DEVICE (LVAD);

ARTIFICIAL ORGANS;

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; ARGATROBAN; ATAPROST; FIBRINOGEN; HEPARIN; NAFAMSTAT MESILATE; PROSTACYCLIN DERIVATIVE; THROMBIN; THROMBIN INHIBITOR;

ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; ARTIFICIAL HEART; BLEEDING TENDENCY; BLOOD CLOTTING; BLOOD PUMP; CONTROLLED STUDY; DOG; FIBRINOLYSIS; HEART ASSIST DEVICE; NONHUMAN; THROMBOCYTE AGGREGATION;

EID: 0034063060     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-200005000-00022     Document Type: Article

References (3)

1. Okamaoto S, Hijikata A, Kikumoto R, et al: Potent inhibition of thrombin by the newly synthesized arginine derivative no. 805: The importance of stereostructure of its hydrophobia carboxamide portion. Biochem Biophy Res Commun 101: 440-446, 1981.
2. Fujii S, Hitomi Y: New synthetic inhibitors of C1r, C1, elastase, thrombin, plasmin, kallikrein and trypsin. Biochim Biophys Acta 661: 342-345, 1981.
3. Aoyama T, Ino Y, Ozeki M, et al: Pharmacological studies of FUT-175, nafamostat mesylate: I. Inhibition of protease activity in in vitro and in vivo experiments. Jpn J Pharmacol 35: 203-227, 1984.